BioSpace News Archive

Monitoring is the regular observation and recording of activities and vitals when animals are under anesthesia and also identifying other disease conditions.

Over the past two to three decades, considerable efforts have been made to develop and improve global health, particularly in underdeveloped and developing regions.

Within the global healthcare ecosystem, concerns pertaining to the use of radiation and diagnostic imaging tests have led to a considerable rise in the research and development expenditure.

Fluconazole is an antifungal medication that belongs to a class of drugs called azole antifungals, which are used for various yeast and fungal infections such as oropharyngeal candidiasis, vaginal candidiasis, esophageal candidiasis, fungal meningitis and other candida infections including urinary tract infection and peritonitis.

Bone-regeneration techniques, either with autografts or allografts, represent a challenge for reconstructive surgery.

The rise in awareness about oral care and the growing cases of periodontal illnesses and tooth caries all across the world have prompted the advancement of the expert dental care market.

An apheresis machine comprises of a gadget or device which gathers blood removed from the body of the donor and separates it into the diverse components, for instance, platelets, plasma, platelets, red and white platelets.

Almirall, S.A. (BME:ALM), a global biopharmaceutical company focused on skin health, announced today that Klisyri® (tirbanibulin) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis (AK) of the face or scalp

HORIBA Medical, a leading global diagnostic company providing solutions in chemistry, hematology and hemostasis, today announced that it has obtained U.S. Food and Drug Administration (FDA) and Health Canada clearance in North America for its next generation clinical chemistry system, the Yumizen C1200.

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced the appointment of Christopher (Chris) Kurtz as executive vice president of technical operations. Mr. Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program manageme